Abstract
The manipulation of mice genome is a powerful technique to analyze biological processes that cannot be studied in tissue culture (1). The understanding of many developmental processes is today improving because of such techniques. This is also changing the way human genetic diseases are studied. It is now possible to reproduce in laboratory mice the same genetic defects identified in human diseases and, taking species differences into account, to mimic the pathological events that lead to the specific diseases. This allows a developmental, biochemical, and genetic study of human disorders that, for ethical, clinical, or practical reasons, was impossible before. Indeed, the study of genetic diseases of the skeleton has received a great benefit from the generation and the analysis of genetically engineered mutants. However, the availability of such mutants is still limited and considerable effort is required to genetically dissect the pathways that can alter skeletal development. Although such pathways may be very well conserved in Drosophila or Zebrafish, the formation of bone and cartilage is a function acquired later in evolution that cannot be extrapolated from invertebrates and lower vertebrates. These organisms are not the ideal organisms to model human diseases of the skeleton. Therefore, the laboratory mouse is very rapidly becoming the experimental animal of choice to generate mutant animals that carry defects at different checkpoints of cartilage and bone formation (also see Chapters 43 by Jacenko and 45 by Liu, Snead, and Maxson in this volume).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994) Manipulating the Mouse Embryo: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Cheah, K. S., Lau, E. T., Au, P. K., and Tam, P. P. (1991) Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development. Development 111(4), 945–953.
Horton, W., Miyashita, T., Kohno, K., Hassell, J. R., and Yamada, Y. (1987) Identification of a phenotype-specific enhancer in the first intron of the rat collagen II gene. Proc. Natl. Acad. Sci. USA 84, 8864–8868.
Mukhopadhyay, K., Lefebvre, V., Zhou, G., Garofalo, S., Kimura, J. H., and de Crombrugghe, B. (1995) Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promotersegments in the mouse proα1(II) collagen gene. J. Biol. Chem. 270(46), 27,711–27,719.
Zhou, G., Garofalo, S., Mukhopadhyay, K., Lefebvre, V., Smith, C., Eberspaecher, H., and de Crombrugghe, B. (1995) A 182 bp fragment of the mouse pro-a1(II) collagen gene is sufficient to direct chondrocyte-specific expression in transgenic mice. J. Cell Sci. 108, 3677–3684.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Garofalo, S., Horton, W.A. (2000). Genetic-Engineered Models of Skeletal Diseases II. In: Tuan, R.S., Lo, C.W. (eds) Developmental Biology Protocols. Methods in Molecular Biology™, vol 137. Humana Press. https://doi.org/10.1385/1-59259-066-7:491
Download citation
DOI: https://doi.org/10.1385/1-59259-066-7:491
Publisher Name: Humana Press
Print ISBN: 978-0-89603-854-7
Online ISBN: 978-1-59259-066-7
eBook Packages: Springer Protocols